Roche, Lead Pharma partner to develop oral small molecules for immune-mediated diseases

Roche, Lead Pharma partner to develop oral small molecules for immune-mediated diseases

Submitted by admin on November 16, 2020 - 10:31am
Source: 
Pharmaceutical Business Review
News Tags: 
Roche
Lead Pharma
small molecule drugs
drug development
immune disorders
Headline: 
Roche, Lead Pharma partner to develop oral small molecules for immune-mediated diseases
snippet: 

Lead Pharma has signed a collaboration and license agreement with Roche for the development of oral small molecules to treat a range of immune-mediated diseases.

Do Not Allow Advertisers to Use My Personal information